Zilebesiran Investigational RNAi therapy in Phase 3 development for hypertension, with Alnylam leading a partnered program designed to sustain blood pressure control.
Visit productCosigns Received
Be the first Cosign
Put your name behind Zilebesiran.
Add it to your Products I use list and share why you use it.